Biomedica Foscama Industria Chimico-Farmaceutica S.p.a. S.C. Sindan-Pharma S.R.L.

Poland

All drugs from this manufacturer

  • NAMAXIR

    The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 15 mg

    ATC: L04AX03

  • The medicinal product is used in the treatment of active rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 20 mg

    ATC: L04AX03

  • This medicine is used to treat active rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 25 mg

    ATC: L04AX03

  • The medicine is used in the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease (mild to moderate course).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 7.5 mg

    ATC: L04AX03

  • The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 10 mg

    ATC: L04AX03